CD28 and neoplasm: Huang et al. demonstrated high expression of IL-10, low CD56+ and CD28+ cell infiltration in tumor samples, a low percentage of CD3− CD56+ NK cells, high CD3+ CD8+ CD28− T cells, and IL-10 in peripheral blood in patients with invasive NF-PitNETs [26].